http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0619747-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df05e1a249c7498d76ba1afb3e82ff97 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-812 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate | 2006-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b062471c2e1591d9489e3e3d50f52484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a96a220d50f058af3c6b0bfda215adef |
| publicationDate | 2011-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-PI0619747-A2 |
| titleOfInvention | method for producing a therapeutic vaccine composition, antigenic construct, vaccine composition, uses of an antigenic abet peptide fragment, an antigenic peptide antigen or an antigenic construct, methods for treating an amyloid-associated condition or disease, to significantly increase the retention or cognitive memory capacity of a mammal to induce an immune response in an animal, to prepare and produce a medicament for the treatment of an amyloid-associated condition or disease, and antibody or antibody mixture |
| abstract | METHOD TO PRODUCE A THERAPEUTIC VACCINE COMPOSITION, ANTIGENIC CONSTRUCTION, VACCINE COMPOSITION, USES OF A FETA ANTIGENIC PEPTIDE FRAGMENT, AN ABETA PEPTIDE ANTIGEN, OR A ANTIGENIC CONTAINER, AGAINST AGENT THE RETENTION OR CAPACITY OF COGNITIVE MEMORY OF A MAMMALIAN, TO INDUCT AN IMMUNE RESPONSE IN AN ANIMAL, TO PREPARE AND PRODUCE A MEDICINE FOR THE TREATMENT OF A CONDITION OR DISEASE ASSOCIATED WITH AMYLOID, AND, ANTIBODY OR MIXTURE OF ANTIBODIES. The present invention relates to methods and compositions for diagnostic and therapeutic use in the treatment of diseases and disorders that are caused by or are associated with amyloid or amyloid-like proteins including amyloidosis. In particular, the present invention provides new methods and compositions for generating a highly specific and highly effective immune response in an organism, but particularly within an animal, particularly a mammal or a human, which is capable of preventing or alleviating amyloidosis, or the symptoms associated with amyloidosis, a group of diseases and disorders associated with amyloid plaque formation including secondary amyloidosis and age-related amyloidosis including, but not limited to, neurological disorders such as Alzheimer's disease (AD), including characterized diseases or conditions by a loss of cognitive memory capacity such as, for example, mild cognitive impairment (MCI). |
| priorityDate | 2005-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 495.